EMEA-003090-PIP02-22
EMEA-003090-PIP02-22
EMEA-003090-PIP02-22
EMEA-003355-PIP01-22
EMEA-002247-PIP03-17-M01
Human medicines European public assessment report (EPAR): Tepmetko, tepotinib, Date of authorisation: 16/02/2022, Revision: 3, Status: Authorised
EMA confirms recommendation for non-renewal of authorisation of Duchenne muscular dystrophy medicine Translarna
Medical devices: new guidance for industry and notified bodies
Questions and answers on implementation of the medical devices and in vitro diagnostic medical devices Regulations ((EU) 2017/745 and (EU) 2017/746)
Questions and answers on implementation of the medical devices and in vitro diagnostic medical devices Regulations ((EU) 2017/745 and (EU) 2017/746) - tracked changes
CTIS newsflash - 17 May 2024
Agenda of the CVMP meeting 21-23 May 2024